Table 2 The association of AQP1 and β-catenin in IDC patients.

From: Aquaporin 1 promotes sensitivity of anthracycline chemotherapy in breast cancer by inhibiting β-catenin degradation to enhance TopoIIα activity

 

n

AQP1 expression, n (%)

rs

P value

Low expression (0–2)

High expression (3–9)

β-catenin expression

     

 Low expression (0–2)

156

101 (64.7)

55 (35.3)

0.124

0.022

 High expression (3–9)

185

97 (52.4)

88 (47.6)

–

–

  1. P value was calculated by Spearman’s Rank-Correlation test.
Back to article page